Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dongkook Pharmaceutical Co., Ltd.
Age
19–50
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Men aged 19 to 50 years
Body weight 55 to 90 kg and BMI 18.0 to 27.0
Voluntarily signed the informed consent form
Eligible according to the screening test results
Available to follow up after drop-out
You may not be if
Clinically significant disorders or a medical history of hepatic, renal, neurological, respiratory, endocrine, hemato-oncologic, cardiovascular, urological and psychiatric diseases
Hypersensitivity to donepezil, piperidine derivatives and other drugs
SBP \<100 mmHg or \>150 mmHg, or DBP \<60 mmHg or \>100 mmHg
Skin and muscle disorders or history of surgery at the injection site
AST or ALT \>1.5xULN; QT/QTcB interval \>450 ms
History or positive result of drug abuse
Prescribed drugs or herbal medicines within 2 weeks, over-the-counter drugs or vitamins within 1 week
Participated in other clinical trials within 3 months
Donated whole blood within 2 months or apheresis within 1 month, or transfusion within 1 month
